Next Article in Journal
Major Histocompatibility Complex Class I and Tumour Immuno-Evasion: How to Fool T Cells and Natural Killer Cells at One Time
Previous Article in Journal
Challenges in Knowledge Translation: The Early Years of Cancer Care Ontario’s Program in Evidence-Based Care
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Understanding and Overcoming Chemoresistance in Ovarian Cancer: Emerging Role of the Endothelin Axis

Molecular Pathology Laboratory A, Regina Elena National Cancer Institute, Rome, Italy
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2012, 19(1), 36-38; https://doi.org/10.3747/co.19.895
Submission received: 6 November 2011 / Revised: 4 December 2011 / Accepted: 2 January 2012 / Published: 1 February 2012

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Epithelial ovarian cancer ( EOC) is the leading cause of gynecologic cancer mortality worldwide. [...]
Keywords: ovarian carcinoma; epithelial-to-mesenchymal transition; endothelin; chemoresistance; Snail ovarian carcinoma; epithelial-to-mesenchymal transition; endothelin; chemoresistance; Snail

Share and Cite

MDPI and ACS Style

Bagnato, A.; Rosanò, L. Understanding and Overcoming Chemoresistance in Ovarian Cancer: Emerging Role of the Endothelin Axis. Curr. Oncol. 2012, 19, 36-38. https://doi.org/10.3747/co.19.895

AMA Style

Bagnato A, Rosanò L. Understanding and Overcoming Chemoresistance in Ovarian Cancer: Emerging Role of the Endothelin Axis. Current Oncology. 2012; 19(1):36-38. https://doi.org/10.3747/co.19.895

Chicago/Turabian Style

Bagnato, A., and L. Rosanò. 2012. "Understanding and Overcoming Chemoresistance in Ovarian Cancer: Emerging Role of the Endothelin Axis" Current Oncology 19, no. 1: 36-38. https://doi.org/10.3747/co.19.895

Article Metrics

Back to TopTop